RUCHIRA SENGUPTA

Allopathic & Osteopathic Physicians|Internal Medicine|Critical Care Medicine GRAND RAPIDS, MI NPI 1669813259

General Payments — all program years on this page

$1,379.29

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 59
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $420.82 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $420.8219

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $39.371
2020 $51.683
2021 $60.944
2022 $297.4514
2023 $509.0318
2024 $420.8219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078893601 Actelion Pharmaceuticals US, Inc. $18.55 12/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089563154 Insmed, Inc. $17.18 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104214143 AstraZeneca Pharmaceuticals LP $49.53 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104603946 AstraZeneca Pharmaceuticals LP $18.70 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105497041 AstraZeneca Pharmaceuticals LP $22.78 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105529436 AstraZeneca Pharmaceuticals LP $19.20 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105548569 AstraZeneca Pharmaceuticals LP $14.91 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105618649 AstraZeneca Pharmaceuticals LP $16.55 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105812245 AstraZeneca Pharmaceuticals LP $18.79 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114166336 Regeneron Healthcare Solutions, Inc. $18.93 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114166338 Regeneron Healthcare Solutions, Inc. $28.38 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116220618 GlaxoSmithKline, LLC. $27.61 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116367747 GlaxoSmithKline, LLC. $15.53 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116580255 GlaxoSmithKline, LLC. $14.23 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137671712 Takeda Pharmaceuticals U.S.A., Inc. $28.86 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139976445 GENZYME CORPORATION $17.45 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139976455 GENZYME CORPORATION $30.00 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147294169 Mylan Specialty L.P. $18.53 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147359982 Mylan Specialty L.P. $25.11 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.